[ Price : $8.95]
Five bipartisan members of Congress ask HHS and CMS to include unique device identifiers on health insurance claims forms to enhan...[ Price : $8.95]
FDA releases the FDA-483 with three observations from an inspection at Nubratori, Inc.[ Price : $8.95]
Immunomedics resubmits its BLA seeking accelerated approval for sacituzumab govitecan, indicated for treating certain patients wit...[ Price : $8.95]
A Ropes&Gray legal analysis says a recent Supreme Court decision could make it easier for regulated companies to argue against cou...[ Price : $8.95]
The 3rd Circuit Court of Appeals asks a New Jersey federal court to look at hundreds of Fosamax bone fracture cases and determine ...[ Price : $8.95]
FDA clears a NeuroOne Medical Technologies 510(k) to market its thin film cortical electrode technology for temporary (less than 3...[ Price : $8.95]
Immunomedics resubmits its BLA seeking accelerated approval for sacituzumab govitecan, indicated for treating certain patients wit...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Ultragenyxs Crysvita.